Changan Yu

613 total citations
32 papers, 487 citations indexed

About

Changan Yu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Changan Yu has authored 32 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Changan Yu's work include Acute Myocardial Infarction Research (6 papers), Coronary Interventions and Diagnostics (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Changan Yu is often cited by papers focused on Acute Myocardial Infarction Research (6 papers), Coronary Interventions and Diagnostics (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Changan Yu collaborates with scholars based in China, Poland and Canada. Changan Yu's co-authors include Jingang Zheng, Wenqiang Liao, Yanxiang Gao, Jianyan Wen, Shumin Zhao, Ning Xu, Xiangyuan Liu, William Campbell, Bi Chen and Changling Li and has published in prestigious journals such as Brain Research, Journal of Ethnopharmacology and Medicine.

In The Last Decade

Changan Yu

32 papers receiving 484 citations

Peers

Changan Yu
Changan Yu
Citations per year, relative to Changan Yu Changan Yu (= 1×) peers Spomenka Ljubić

Countries citing papers authored by Changan Yu

Since Specialization
Citations

This map shows the geographic impact of Changan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changan Yu more than expected).

Fields of papers citing papers by Changan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changan Yu. The network helps show where Changan Yu may publish in the future.

Co-authorship network of co-authors of Changan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Changan Yu. A scholar is included among the top collaborators of Changan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changan Yu. Changan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yike, Ziyu Guo, Enmin Xie, et al.. (2023). Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials. Frontiers in Cardiovascular Medicine. 10. 1102717–1102717. 3 indexed citations
3.
Guo, Jing, Yuting Zhang, Lesi Cai, et al.. (2023). Pulmonary rehabilitation restores limb muscle mitochondria and improves the intramuscular metabolic profile. Chinese Medical Journal. 136(4). 461–472. 2 indexed citations
4.
Xie, Enmin, Yanxiang Gao, Ziyu Guo, et al.. (2022). Triglyceride glucose index exacerbates the risk of future cardiovascular disease due to diabetes: evidence from the China Health and Retirement Longitudinal Survey (CHARLS). BMC Cardiovascular Disorders. 22(1). 236–236. 14 indexed citations
5.
Li, Qing, Enmin Xie, Yaxin Wu, et al.. (2022). Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention. International Journal of Cardiology. 369. 13–18. 2 indexed citations
6.
Xie, Enmin, Yanxiang Gao, Ziyu Guo, et al.. (2022). The triglyceride glucose index is associated with future cardiovascular disease nonlinearly in middle-aged and elderly Chinese adults. BMC Endocrine Disorders. 22(1). 242–242. 6 indexed citations
7.
Li, Qing, Ziyu Guo, Chao Wu, et al.. (2022). Ischemia preconditioning alleviates ischemia/reperfusion injury-induced coronary no-reflow and contraction of microvascular pericytes in rats. Microvascular Research. 142. 104349–104349. 13 indexed citations
8.
Li, Qing, Chao Wu, Enmin Xie, et al.. (2022). Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice. Frontiers in Cardiovascular Medicine. 9. 995216–995216. 15 indexed citations
9.
Wu, Chao, Yan Fang, Min Li, et al.. (2021). Whole-Mount Kidney Clearing and Visualization Reveal Renal Sympathetic Hyperinnervation in Heart Failure Mice. Frontiers in Physiology. 12. 696286–696286. 5 indexed citations
10.
Yan, Mengwen, Ying Zhou, Changan Yu, et al.. (2021). Interleukin‐7 aggravates myocardial ischaemia/reperfusion injury by regulating macrophage infiltration and polarization. Journal of Cellular and Molecular Medicine. 25(21). 9939–9952. 19 indexed citations
11.
Xu, Hao, Zhuo Chen, Qinghua Shang, et al.. (2019). Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of “Toxin Syndrome” in Coronary Heart Disease. Chinese Journal of Integrative Medicine. 25(5). 327–333. 4 indexed citations
12.
Wang, Zhizhi, Shanshan Wang, Changan Yu, et al.. (2019). Naringenin Ameliorates Renovascular Hypertensive Renal Damage by Normalizing the Balance of Renin-Angiotensin System Components in Rats. International Journal of Medical Sciences. 16(5). 644–653. 43 indexed citations
13.
Wu, Wenjing, Jiahui Li, Changan Yu, et al.. (2018). Association of serum ADAMTS-7 levels with left ventricular reverse remodeling after ST-elevation myocardial infarction. European journal of medical research. 23(1). 15–15. 4 indexed citations
14.
Wang, Lianmei, Chunying Li, Yong Zhao, et al.. (2018). Oral administration of Aristolochia manshuriensis Kom in rats induces tumors in multiple organs. Journal of Ethnopharmacology. 225. 81–89. 20 indexed citations
15.
Wu, Wenjing, Hui Wang, Changan Yu, et al.. (2016). Association of ADAMTS-7 Levels with Cardiac Function in a Rat Model of Acute Myocardial Infarction. Cellular Physiology and Biochemistry. 38(3). 950–958. 11 indexed citations
16.
Zhang, Wenjian, Jianyan Wen, Meng Wang, et al.. (2015). A Preliminary Study of the Therapeutic Role of Human Early Fetal Aorta-derived Endothelial Progenitor Cells in Inhibiting Carotid Artery Neointimal Hyperplasia. Chinese Medical Journal. 128(24). 3357–3362. 4 indexed citations
17.
Gao, Yanxiang, Wenjing Wu, Changan Yu, et al.. (2015). A disintegrin and metalloproteinase with thrombospondin motif 1 (ADAMTS1) expression increases in acute aortic dissection. Science China Life Sciences. 59(1). 59–67. 24 indexed citations
18.
Gao, Yanxiang, et al.. (2013). ADAMTS-7 Expression Increases in the Early Stage of Angiotensin II-Induced Renal Injury in Elderly Mice. Kidney & Blood Pressure Research. 38(1). 121–131. 17 indexed citations
19.
Chen, Bi, Wenqiang Liao, Ning Xu, et al.. (2009). Adiponectin protects against cerebral ischemia–reperfusion injury through anti-inflammatory action. Brain Research. 1273. 129–137. 98 indexed citations
20.
Liao, Wenqiang, Changan Yu, Jianyan Wen, et al.. (2008). Adiponectin induces interleukin‐6 production and activates STAT3 in adult mouse cardiac fibroblasts. Biology of the Cell. 101(5). 263–272. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026